| Assay Type | Assay Response | Assay Units |
|---|
| any method | 3D structure | |
| any method | antibody binding | |
| binding assay | association constant KA | 1/nM |
| binding assay | dissociation constant KD | nM |
| binding assay | off rate | 1/s |
| binding assay | on rate | M^-1s^-1 |
| binding assay | qualitative binding | |
| bio-layer interferometry assay | dissociation constant KD | nM |
| bio-layer interferometry assay | off rate | 1/s |
| bio-layer interferometry assay | on rate | M^-1s^-1 |
| bio-layer interferometry assay | qualitative binding | |
| biological activity | agglutination | |
| biological activity | antibody activity inhibition | |
| biological activity | antibody-dependent cellular cytotoxicity | |
| biological activity | antigen activation | |
| biological activity | complement-dependent cytotoxicity | |
| biological activity | hemagglutination inhibition | |
| biological activity | histamine release | |
| biological activity | in vivo activity | |
| biological activity | neutralization | |
| biological activity | opsonization | |
| biological activity | secondary in vitro activity | |
| calorimetry | association constant KA | 1/nM |
| calorimetry | dissociation constant KD | nM |
| calorimetry | qualitative binding | |
| chromatography | association constant KA | 1/nM |
| chromatography | dissociation constant KD | nM |
| chromatography | qualitative binding | |
| cross blocking | qualitative binding | |
| electron microscopy | 3D structure | |
| electron microscopy | qualitative binding | |
| ELISA | association constant KA | 1/nM |
| ELISA | dissociation constant KD | nM |
| ELISA | qualitative binding | |
| ELISPOT | qualitative binding | |
| flow cytometry | qualitative binding | |
| footprinting assay | qualitative binding | |
| High throughput multiplexed assay | antibody binding | |
| hydrogen/deuterium exchange footprinting assay | qualitative binding | |
| hydroxyl-radical footprinting assay | qualitative binding | |
| immuno staining | qualitative binding | |
| immunohistochemistry | qualitative binding | |
| immunoprecipitation | qualitative binding | |
| in vivo assay | decreased disease | |
| in vivo assay | decreased disease after adoptive transfer | |
| in vivo assay | disease exacerbation | |
| in vivo assay | disease exacerbation after adoptive transfer | |
| in vivo assay | hypersensitivity | |
| in vivo assay | hypersensitivity after adoptive transfer | |
| in vivo assay | pathogen burden after challenge | |
| in vivo assay | pathogen burden after challenge after adoptive transfer | |
| in vivo assay | protection from challenge | |
| in vivo assay | protection from challenge after adoptive transfer | |
| in vivo assay | protection from fertility | |
| in vivo assay | protection from other challenge | |
| in vivo assay | protection from other challenge after adoptive transfer | |
| in vivo assay | protection from pathogen challenge | |
| in vivo assay | protection from pathogen challenge after adoptive transfer | |
| in vivo assay | protection from tumor challenge | |
| in vivo assay | protection from tumor challenge after adoptive transfer | |
| in vivo assay | survival after pathogen challenge after adoptive transfer | |
| in vivo assay | survival after tumor challenge after adoptive transfer | |
| in vivo assay | survival from challenge | |
| in vivo assay | survival from challenge after adoptive transfer | |
| in vivo assay | survival from pathogen challenge | |
| in vivo assay | survival from tumor challenge | |
| in vivo assay | tolerance | |
| in vivo assay | tolerance after adoptive transfer | |
| in vivo assay | tumor burden after challenge | |
| in vivo assay | tumor burden after challenge after adoptive transfer | |
| inhibition by antigen | qualitative binding | |
| inhibition by antigen (~ IC50) | dissociation constant KD | nM |
| mass spectrometry | qualitative binding | |
| microarray | qualitative binding | |
| nuclear magnetic resonance (NMR) | 3D structure | |
| nuclear magnetic resonance (NMR) | dissociation constant KD | nM |
| nuclear magnetic resonance (NMR) | qualitative binding | |
| phage display | qualitative binding | |
| quartz crystal microbalance | dissociation constant KD | nM |
| quenching | association constant KA | 1/nM |
| quenching | dissociation constant KD | nM |
| quenching | off rate | 1/s |
| quenching | on rate | M^-1s^-1 |
| quenching | qualitative binding | |
| radio immuno assay (RIA) | association constant KA | 1/nM |
| radio immuno assay (RIA) | dissociation constant KD | nM |
| radio immuno assay (RIA) | qualitative binding | |
| small-angle scattering assay | 3D structure | |
| surface plasmon resonance (SPR) | association constant KA | 1/nM |
| surface plasmon resonance (SPR) | dissociation constant KD | nM |
| surface plasmon resonance (SPR) | off rate | 1/s |
| surface plasmon resonance (SPR) | on rate | M^-1s^-1 |
| surface plasmon resonance (SPR) | qualitative binding | |
| western blot | qualitative binding | |
| x-ray crystallography | 3D structure | angstroms |